PL3494122T3 - Podstawione rybonukleozydy heteropentadienopirolopirymidynowe do użytku terapeutycznego - Google Patents
Podstawione rybonukleozydy heteropentadienopirolopirymidynowe do użytku terapeutycznegoInfo
- Publication number
- PL3494122T3 PL3494122T3 PL17768661T PL17768661T PL3494122T3 PL 3494122 T3 PL3494122 T3 PL 3494122T3 PL 17768661 T PL17768661 T PL 17768661T PL 17768661 T PL17768661 T PL 17768661T PL 3494122 T3 PL3494122 T3 PL 3494122T3
- Authority
- PL
- Poland
- Prior art keywords
- therapeutic use
- pyrrolopyrimidine ribonucleosides
- substituted heteropentadieno
- heteropentadieno
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ2016-465A CZ307334B6 (cs) | 2016-08-02 | 2016-08-02 | Substituované heteropentadieno-pyrrolopyrimidinové ribonukleosidy pro terapeutické použití |
| PCT/CZ2017/050031 WO2018024265A1 (en) | 2016-08-02 | 2017-07-31 | Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides for therapeutic use |
| EP17768661.5A EP3494122B1 (en) | 2016-08-02 | 2017-07-31 | Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides for therapeutic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3494122T3 true PL3494122T3 (pl) | 2020-03-31 |
Family
ID=59901302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17768661T PL3494122T3 (pl) | 2016-08-02 | 2017-07-31 | Podstawione rybonukleozydy heteropentadienopirolopirymidynowe do użytku terapeutycznego |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10730905B2 (pl) |
| EP (1) | EP3494122B1 (pl) |
| JP (1) | JP6685475B2 (pl) |
| CA (1) | CA3031049C (pl) |
| CZ (1) | CZ307334B6 (pl) |
| ES (1) | ES2761050T3 (pl) |
| PL (1) | PL3494122T3 (pl) |
| WO (1) | WO2018024265A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ308104B6 (cs) * | 2018-03-12 | 2020-01-08 | Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v. v. i. | Pyridinopyrrolopyrimidinové ribonukleosidy pro terapeutické použití |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007504152A (ja) * | 2003-08-27 | 2007-03-01 | ビオタ， インコーポレイテッド | 治療剤としての新規三環ヌクレオシドまたはヌクレオチド |
| PL3133080T3 (pl) | 2008-01-18 | 2018-12-31 | Inst Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Nowe cytostatyczne nukleozydy 7-deazapurynowe |
| DK2421879T3 (da) | 2009-04-22 | 2013-11-25 | Acad Of Science Czech Republic | Nye 7-deazapurinnukleotider til terapeutiske anvendelser |
| CZ305466B6 (cs) * | 2013-11-04 | 2015-10-14 | Ústav organické chemie a biochemie Akademie věd České republiky, v. v. i. | Substituované 7-deazapurinové ribonukleosidy pro terapeutické použití |
| US9586986B2 (en) * | 2014-12-05 | 2017-03-07 | Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. | Substituted 7-deazapurine ribonucleosides for therapeutic uses |
-
2016
- 2016-08-02 CZ CZ2016-465A patent/CZ307334B6/cs unknown
-
2017
- 2017-07-31 CA CA3031049A patent/CA3031049C/en active Active
- 2017-07-31 ES ES17768661T patent/ES2761050T3/es active Active
- 2017-07-31 JP JP2019523161A patent/JP6685475B2/ja active Active
- 2017-07-31 US US16/308,796 patent/US10730905B2/en active Active
- 2017-07-31 WO PCT/CZ2017/050031 patent/WO2018024265A1/en unknown
- 2017-07-31 PL PL17768661T patent/PL3494122T3/pl unknown
- 2017-07-31 EP EP17768661.5A patent/EP3494122B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019522057A (ja) | 2019-08-08 |
| CZ307334B6 (cs) | 2018-06-13 |
| CZ2016465A3 (cs) | 2018-02-14 |
| US20190144486A1 (en) | 2019-05-16 |
| ES2761050T3 (es) | 2020-05-18 |
| CA3031049A1 (en) | 2018-02-08 |
| EP3494122A1 (en) | 2019-06-12 |
| US10730905B2 (en) | 2020-08-04 |
| WO2018024265A1 (en) | 2018-02-08 |
| CA3031049C (en) | 2020-07-07 |
| JP6685475B2 (ja) | 2020-04-22 |
| EP3494122B1 (en) | 2019-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1256383A1 (zh) | 治療劑 | |
| GB201509893D0 (en) | Therapeutic agents | |
| GB201517263D0 (en) | Therapeutic agents | |
| GB201603104D0 (en) | Therapeutic agents | |
| HK1258727A1 (zh) | 治療性化合物 | |
| GB201502412D0 (en) | Therapeutic use | |
| GB201608797D0 (en) | Therapeutic use | |
| GB201716942D0 (en) | Therapeutic compounds | |
| GB201509885D0 (en) | Therapeutic agents | |
| GB201509888D0 (en) | Therapeutic agents | |
| GB201617339D0 (en) | Therapeutic compounds | |
| GB201616839D0 (en) | Therapeutic compounds | |
| GB201700553D0 (en) | Therapeutic agents | |
| GB201513299D0 (en) | Therapeutic agents | |
| GB201600376D0 (en) | Novel therapeutic agents | |
| GB201521767D0 (en) | Therapeutic agents | |
| PL3494122T3 (pl) | Podstawione rybonukleozydy heteropentadienopirolopirymidynowe do użytku terapeutycznego | |
| IL263821A (en) | Medicinal compounds | |
| GB201517264D0 (en) | Therapeutic agents | |
| GB201506786D0 (en) | Therapeutic use | |
| PL3765475T3 (pl) | Podstawione rybonukleozydy pirydopirolopirymidynowe do zastosowań terapeutycznych | |
| GB2558788B (en) | New therapeutic uses | |
| GB201712393D0 (en) | Therapeutic compounds | |
| GB201712392D0 (en) | Therapeutic compounds | |
| GB201712394D0 (en) | Therapeutic compounds |